Does comparative genomic hybridization reveal distinct differences in DNA copy number sequence patterns between leiomyosarcoma and malignant fibrous histiocytoma?

Cancer Genetics and Cytogenetics

Volumn 187, Issue 1, 2008, Pages 1-11

  Larramendy, Marcelo L ^a,b   Gentile, Massimiliano ^c   Soloneski, Sonia ^b   Knuutila, Sakari ^a   Böhling, Tom ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b FACULTAD DE CIENCIAS NATURALES Y MUSEO   (Argentina)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GROWTH; CELL DIFFERENTIATION; CHROMOSOME 17Q; CHROMOSOME 19P; CHROMOSOME 1P; CHROMOSOME 22P; CHROMOSOME 22Q; CHROMOSOME ABERRATION; CHROMOSOME BAND; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DNA SEQUENCE; FEMALE; GENE AMPLIFICATION; GENE FUNCTION; HUMAN; HUMAN TISSUE; LEIOMYOSARCOMA; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEX DIFFERENCE; SMOOTH MUSCLE FIBER; THIGH;

ACTINS; ALGORITHMS; BASE SEQUENCE; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN; CLUSTER ANALYSIS; DNA, NEOPLASM; GENE AMPLIFICATION; HISTIOCYTOMA, MALIGNANT FIBROUS; HUMANS; LEIOMYOSARCOMA; NUCLEIC ACID HYBRIDIZATION;

EID: 55249100796     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2008.06.005     Document Type: Article

References (53)

1. Weiss S.W., and Goldblum J.R. Leiomyosarcoma. In: Weiss S.W., and Goldblum J.R. (Eds). Enzinger and Weiss's soft tissue tumors. 4th ed. (2001), Mosby Harcourt, Philadelphia 727-748
2. Trzyna W., McHugh M., McCue P., and McHugh K.M. Molecular determination of the malignant potential of smooth muscle neoplasms. Cancer 80 (1997) 211-217
3. Waldmann J., Stachs A., Terpe H., Stropahl G., and Makovitzky J. Smooth muscle tumours of the uterine corpus: a clinicopathologic study with immunohistochemical aspects. Anticancer Res 25 (2005) 1559-1565
4. Loddenkemper C., Mechsner S., Foss H.D., Dallenbach F.E., Anagnostopoulos I., Ebert A.D., and Stein H. Use of oxytocin receptor expression in distinguishing between uterine smooth muscle tumors and endometrial stromal sarcoma. Am J Surg Pathol 27 (2003) 1458-1462
5. Weiss S.W. Histological typing of soft tissue tumours. 2nd ed. (1994), Springer-Verlag, Berlin
6. Dehner L.P. Malignant fibrous histiocytoma: nonspecific morphologic pattern, specific pathologic entity, or both?. Arch Pathol Lab Med 112 (1988) 236-237
7. Fletcher C.D.M. Malignant fibrous histiocytoma?. Histopathology 11 (1987) 433-437
8. Hollowood K., and Fletcher C.D.M. Malignant fibrous histiocytoma: morphologic pattern or pathologic entity?. Semin Diagn Pathol 12 (1995) 210-220
9. Fletcher C.D.M., van den Berg E., and Molenaar W.M. Pleomorphic malignant fibrous histiocytoma/undifferentiated high grade pleomorphic sarcoma. In: Fletcher C.D.M., Unni K.K., and Mertens F. (Eds). Pathology and genetics of tumours of soft tissue and bone (2002), IARC Press, World Health Organization Classification of Tumours. Lyon 120-122
10. Mitelman F, Johansson B, Mertens F, editors. Mitelman database of chromosome aberrations in cancer [Internet] [Updated November 2007] Available from http://cgap.nci.nih.gov/Chromosomes/Mitelman. Accessed January 2008.
11. Derré J., Lagacé R., Nicolas A., Mairal A., Chibon F., Coindre J.-M., Terrier P., Sastre X., and Aurias A. Leiomyosarcomas and most malignant fibrous histiocytomas share very similar comparative genomic hybridization imbalances: an analysis of a series of 27 leiomyosarcomas. Lab Invest 81 (2001) 211-215
12. El-Rifai W., Sarloma-Rikala M., Knuutila S., and Miettinen M. DNA copy number changes in development and progression in leiomyosarcomas of soft tissues. Am J Pathol 153 (1998) 985-990
13. Forus A., Weghuis D.O., Smeets D., Fodstad Ø., Myklebost O., and van Kessel A.G. Comparative genomic hybridization analysis of human sarcomas: I. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21-q22 in soft tissue sarcomas. Genes Chromosomes Cancer 14 (1995) 8-14
14. Hu J., Khanna V., Jones M., and Surti U. Genomic alterations in uterine leiomyosarcomas: potential markers for clinical diagnosis. Genes Chromosomes Cancer 31 (2001) 117-124
15. Hu J., Rao U.N., Jasani S., Khanna V., Yaw K., and Surti U. Loss of DNA copy number of 10q is associated with aggressive behavior of leiomyosarcomas: a comparative genomic hybridization study. Cancer Genet Cytogenet 161 (2005) 20-27
16. Larramendy M.L., Kaur S., Svarvar C., Böhling T., and Knuutila S. Gene copy number profiling of soft tissue leiomyosarcoma by array-comparative genomic hybridization. Cancer Genet Cytogenet 169 (2006) 94-101
17. Levy B., Mukherjee T., and Hirschhorn K. Molecular cytogenetic analysis of uterine leiomyoma and leiomyosarcoma by comparative genomic hybridization. Cancer Genet Cytogenet 121 (2000) 1-8
18. Otaño-Joos M., Mechtersheimer G., Ohl S., Wilgenbus K.K., Scheurlen W., Lehnert T., Willeke F., Otto H.F., Lichter P., and Joos S. Detection of chromosomal imbalances in leiomyosarcoma by comparative genomic hybridization and interphase cytogenetics. Cytogenet Cell Genet 90 (2000) 86-92
19. Packenham J.P., du Manoir S., Schrock E., Risinger J.I., Dixon D., Denz D.N., Evans J.A., Berchuck A., Barrett J.C., Devereux T.R., and Ried T. Analysis of genetic alterations in uterine leiomyomas and leiomyosarcomas by comparative genomic hybridization. Mol Carcinog 19 (1997) 273-279
20. Parente F., Grosgeorge J., Coindre J.M., Terrier P., Vilain O., and Turc-Carel C. Comparative genomic hybridization reveals novel chromosome deletions in 90 primary soft tissue tumors. Cancer Genet Cytogenet 115 (1999) 89-95
21. Svarvar C., Larramendy M.L., Blomqvist C., Gentile M., Koivisto-Korander R., Leminen A., Bützow R., Böhling T., and Knuutila S. Do DNA copy number changes differentiate uterine from non-uterine leiomyosarcomas and predict metastasis?. Mod Pathol 19 (2006) 1068-1082
22. Wang R., Lu Y.-J., Fisher C., Bridge J.A., and Shipley J. Characterization of chromosome aberrations associated with soft-tissue leiomyosarcomas by twenty-four-color karyotyping and comparative genomic hybridization analysis. Genes Chromosomes Cancer 31 (2001) 54-64
23. Wang R., Titley J.C., Lu Y.-J., Summersgill B.M., Bridge J.A., Fisher C., and Shipley J. Loss of 13q14-q21 and gain of 5p14-pter in the progression of leiomyosarcoma. Mod Pathol 16 (2003) 778-785
24. Larramendy M.L., Tarkkanen M., Blomqvist C., Virolainen M., Wiklund T., Asko-Seljavaara S., Elomaa I., and Knuutila S. Comparative genomic hybridization of malignant fibrous histiocytoma reveals a novel prognostic marker. Am J Pathol 151 (1997) 1153-1161
25. Kaur S., Larramendy M.L., Vauhkonen H., Böhling T., and Knuutila S. Loss of TP53 in sarcomas with 17p12-p11 gain: a fine-resolution oligonucleotide array comparative genomic hybridization study. Cytogenet Genome Res 116 (2006) 153-157
26. Weng W.H., Åhlén J., Lui W.O., Brosjö O., Pang S.T., Von Rosen A., Auer G., Larsson O., and Larsson C. Gain of 17q in malignant fibrous histiocytoma is associated with a longer disease-free survival and a low risk of developing distant metastasis. Br J Cancer 89 (2003) 720-726
27. Weng W.H., Wejde J., Åhlén J., Pang S.T., Lui W.O., and Larsson C. Characterization of large chromosome markers in a malignant fibrous histiocytoma by spectral karyotyping, comparative genomic hybridization (CGH), and array CGH. Cancer Genet Cytogenet 150 (2004) 27-32
28. Mairal A., Chibon F., Rousselet A., Couturier J., Terrier P., and Aurias A. Establishment of a human malignant fibrous histiocytoma cell line, COMA: characterization by conventional cytogenetics, comparative genomic hybridization, and multiplex fluorescence in situ hybridization. Cancer Genet Cytogenet 121 (2000) 117-123
29. INK4A) and other genomic imbalances in human malignant fibrous histiocytoma. Cancer Genet Cytogenet 118 (2000) 89-98
30. Mairal A., Terrier P., Chibon F., Sastre X., Lecesne A., and Aurias A. Loss of chromosome 13 is the most frequent genomic imbalance in malignant fibrous histiocytomas: a comparative genomic hybridization analysis of a series of 30 cases. Cancer Genet Cytogenet 111 (1999) 134-138
31. Miozzo M., Castorina P., Riva P., Dalprà L., Fuhrman-Conti A.M., Volpi L., Hoe T.S., Khoo A., Wiegant J., Rosenberg C., and Larizza L. Chromosomal instability in fibroblasts and mesenchymal tumors from 2 sibs with Rothmund-Thomson syndrome. Int J Cancer 77 (1998) 504-510
32. Fletcher C.D.M., Gustafson P., Rydholm A., Willén H., and Åkerman M. Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification. J Clin Oncol 12 (2001) 3045-3050
33. Mertens F., Larramendy M., Gustavsson A., Gisselsson D., Rydholm A., Brosjö O., Mitelman F., Knuutila S., and Mandahl N. Radiation-associated sarcomas are characterized by complex karyotypes with frequent rearrangements of chromosome arm 3 p. Cancer Genet Cytogenet 116 (2000) 89-96
34. Coindre J.-M., Mariani O., Chibon F., Mairal A., De Saint Aubain Somerhausen N., Favre-Guillevin E., Bui N.B., Stoeckle E., Hostein I., and Aurias A. Most malignant fibrous histiocytomas developed in the retroperitoneum are dedifferentiated liposarcomas: a review of 25 cases initially diagnosed as malignant fibrous histiocytoma. Mod Pathol 16 (2003) 256-262
35. Sakabe T., Shinomiya T., Mori T., Ariyama Y., Fukuda Y., Fujiwara T., Nakamura Y., and Inazawa J. Identification of a novel gene, MASL1, within an amplicon at 8p23.1 detected in malignant fibrous histiocytomas by comparative genomic hybridization. Cancer Res 59 (1999) 511-515
36. Chibon F., Mariani O., Mairal A., Derré J., Coindre J.-M., Terrier P., Lagacé R., Sastre X., and Aurias A. The use of clustering software for the classification of comparative genomic hybridization data: an analysis of 109 malignant fibrous histiocytomas. Cancer Genet Cytogenet 141 (2003) 75-78
37. Sabah M., Cummins R., Leader M., and Kay E. Leiomyosarcoma and malignant fibrous histiocytoma share similar allelic imbalance pattern in 9 p. Virchows Arch 446 (2005) 251-258
38. Larramendy M.L., El-Rifai W., and Knuutila S. Comparison of fluorescein isothiocyanate- and Texas red-conjugated nucleotides for direct labeling in comparative genomic hybridization. Cytometry 31 (1998) 174-179
39. Larramendy M.L., Tarkkanen M., Valle J., Kivioja A.H., Ervasti H., Karaharju E., Salmivalli T., Elomaa I., and Knuutila S. Gains, losses, and amplifications of DNA sequences evaluated by comparative genomic hybridization in chondrosarcomas. Am J Pathol 150 (1997) 685-691
40. El-Rifai W., Larramendy M.L., Björkqvist A.-M., Hemmer S., and Knuutila S. Optimization of comparative genomic hybridization using fluorochrome conjugated to dCTP and dUTP nucleotides. Lab Invest 77 (1997) 699-700
41. Hochberg Y., and Benjamini Y. More powerful procedures for multiple significance testing. Stat Med 9 (1990) 811-818
42. Coindre J.M., Hostein I., Maire G., Derré J., Guillou L., Leroux A., Ghnassia J.P., Collin F., Pedeutour F., and Aurias A. Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity. J Pathol 203 (2004) 822-830
43. Idbaih A., Coindre J.M., Derré J., Mariani O., Terrier P., Ranchère D., Mairal A., and Aurias A. Myxoid malignant fibrous histiocytoma and pleomorphic liposarcoma share very similar genomic imbalances. Lab Invest 85 (2005) 176-181
44. Kaur S., Larramendy M.L., Gentile M., Svarvar C., Koivisto-Korander R., Vauhkonen H., Scheinin I., Leminen A., Bützow R., Böhling T., and Knuutila S. New insights into the cellular pathways affected in primary uterine leiomyosarcoma. Cancer Genomics Proteomics 3 (2006) 347-354
45. Knuutila S., Aalto Y., Autio K., Björkqvist A.-M., El-Rifai W., Hemmer S., Huhta T., Kettunen E., Kiuru-Kuhlefelt S., Larramendy M.L., Lushnikova T., Monni O., Pere H., Tapper J., Tarkkanen M., Varis A., Wasenius V.-M., Wolf M., and Zhu Y. DNA copy number losses in human neoplasms. Am J Pathol 155 (1999) 683-694
46. Knuutila S., Björkqvist A.-M., Autio K., Tarkkanen M., Wolf M., Monni O., Szymanska J., Larramendy M.L., Tapper J., Pere H., El-Rifai W., Hemmer S., Wasenius V.-M., Vidgren V., and Zhu Y. DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am J Pathol 152 (1998) 1107-1123
47. Chibon F., Mariani O., Derré J., Malinge S., Coindre J.M., Guillou L., Lagacé R., and Aurias A. A subgroup of malignant fibrous histiocytomas is associated with genetic changes similar to those of well-differentiated liposarcomas. Cancer Genet Cytogenet 139 (2002) 24-29
48. Fletcher C.D.M. Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma. Am J Surg Pathol 16 (1992) 213-228
49. Angervall L., Kindblom L.G., and Merck C. Myxofibrosarcoma: a study of 30 cases. Acta Pathol Microbiol Scand [A] 85A (1977) 127-140
50. Schürch W., Bégin L.R., Seemayer T.A., Lagacé R., Boivin J.C., Lamoureux C., Bluteau P., Piché J., and Gabbiani G. Pleomorphic soft tissue myogenic sarcomas of adulthood: a reappraisal in the mid-1990s. Am J Surg Pathol 20 (1996) 131-147
51. Francis P., Fernebro J., Edén P., Laurell A., Rydholm A., Domanski H.A., Breslin T., Hegardt C., Borg A., and Nilbert M. Intratumor versus intertumor heterogeneity in gene expression profiles of soft-tissue sarcomas. Genes Chromosomes Cancer 43 (2005) 302-308
52. Lee Y.F., John M., Edwards S., Clark J., Flohr P., Maillard K., Edema M., Baker L., Mangham D.C., Grimer R., Wooster R., Thomas J.M., Fisher C., Judson I., and Cooper C.S. Molecular classification of synovial sarcomas, leiomyosarcomas and malignant fibrous histiocytomas by gene expression profiling. Br J Cancer 88 (2003) 510-515
53. Potti A., Ganti A.K., Tendulkar K., Sholes K., Chitajallu S., Koch M., and Kargas S. Determination of vascular endothelial growth factor (VEGF) overexpression in soft tissue sarcomas and the role of overexpression in leiomyosarcoma. J Cancer Res Clin Oncol 130 (2003) 52-56